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ABSTRACT
Nine wistar M W-3 pathogen-free rats, selected for this study, were observed for the
effects of cyclohexylamine (CHA) on chromosomes. The rats were divided into three
groups, each consisting of three animals. Group I served as control, group II received
doses of 20 mg/kg body weight, and group III received 50 mg/kg body weight of CHA.
The experiment ran for seven consecutive weeks, with CHA being injected intraperitoneally
for five consecutive days. One day after the last injection, blood was taken from the tail
vein and prepared in vitro for chromosome analysis. The prepared chromosomes were first
observed under light microscope and oil immersion, and chromosome spreads which ap-
peared to be abnormal were photographed for detailed examination.
The results indicate that CHA did not produce any significant chromosme abnor-
malities during the course of this study. It is suggested that longer term experimentation
utilizing a larger number of animals and employing in vitro technique should be considered
in an effort to resolve conflicting results concerning the effects of cyclamates and CHA on
chromosomes.
INTRODUCTION
With the Federal Drug Administration's (FDA) ban on cyclamate in September
of 1969, a great deal of interest has arisen in this field. Prior to and prompting
the ban, a number of researchers studied the biological effects of cyclamate. Fits-
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baugh, et al. (1951) and Nees and Derse (1965) showed reduced growth rate.
Other authors showed bladder cancer (Bryon and Extuch, 1970) and thyroid
adenoma (U.S. Food and Drug Administration 1968). Further complications oc-
curred when Kojuwa and Ichaibagese (1966) and later Chedd (1968) found that
cyclamate is converted to cyclohexylamine (CHA) within the intact organism.
This compound appears to be especially dangerous, and additional reports utiliz-
ing CHA showed chromosome abnormalities in red cells (Stoltz, et al., 1970),
leukocyted and monolayer cells (Stone, el al., 1969), and bone marrow and germ
cells (Legator, et al., 1969). CHA has also been shown to affect the cardiovascular
system (Rosenblum and Rosenblum, 1968, and Yamamura, et al., 1968) and the
nervous system (Legator, et al., 1969). Contrary to these results, a special report
prepared for the FDA clearly denned that neither subcutaneous or topical applica-
tion of cyclamate had any effect in initiating carcinogenic activity (U.S. Food and
Drug. Admin., 1968).
The abundance of evidence concerning the specific effects of cyclamate and
CHA remains contradictory, and considerably more information is needed to
assess accurately the physiological and pathological effects of cyclamate and its
metabolite CHA. The purpose of this study was to determine the effects of dif-
ferent-sized doses of CHA injected intraperitoneally on the chromosomes of cir-
culating blood of rats.
METHODS AND MATERIALS
Nine Wistar M W-3 pathogen-free rats were used for this study. All of the
animals were less than one year old and were maintained three in a cage at a room
temperature of 23.5OC±1°C. Food and water were provided ad libitum. The
rats were divided arbitrarily into three groups of three rats each. Group I served
as control, group II received doses of 20 mg/Kg body weight of CHA, and group
III received doses of 50 mg/Kg; all injected doses were adjusted to a pH of 7.4
with HC1. Table 1 shows the vital data and doses for the animals used during the
experiment.
The experiment ran for seven weeks, during which time the following procedure
was followed. Each week of the experiment, each experimental animal was
injected, intraperitoneally, with cyclohexylamine for five consecutive days.
Twenty-four hours after the fifth injection, blood was taken from each rat's tail
vein. Blood from each animal was transferred by using a heparinized sterile
capillary pipette to a commercial chromosome preparation medium (chromosome
medium 1A, Grand Island Biological Co.).
The preparation was incubated at 37°C±1°C for 72 to 96 hours. At the end
of the incubation period, 0.1 ml of colchicine was added to each tube, and the
total sample was maintained at the incubation temperature for 1% to 2 hours.
The preparation was then centrifuged at 1000 RPM for 5 minutes, at which time
5 ml of buffered saline solution was added slowly to each sample, after which the
sample was again incubated at 37°C for 15 minutes. Following this, one drop
of freshly mixed fixitive (acetic acid-alcohol 3:1) was added and the mixture was
again centrifuged at 1000 RPM for five minutes. An additional 2 ml of fixitive
was added and maintained at O°C for twenty minutes. Finally an additional 2
ml of fixitive was added to maximize chromosome stability. After the last cen-
trifugation, approximately one third of the supernatant was retained and mixed
with the remaining cells, which were then placed on a cold, wet slide. The excess
fluid was drained on a paper towel and the slide passed over a small flame to
partially dry it. When the slides were completely air dry, they were treated with
Geimsa stain for fifteen minutes and then with Jenner stain for another fifteen
minutes. They were then rinsed three times in distilled water, again air dried,
and a cover glass was mounted. Four to five slides were prepared from each
animal each week in this manner.
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The mounted slides were first scanned, using the lower power of a standard
light microscope, to locate well-separated chromosome spreads. These identified
spreads were then examined again, using an oil-immersion lens. Fifty spreads of
the metaphase stage of the chromosomes were examined for each of the three
groups. Spreads which appeared on vision to show possible abnormalities were
photographed and enlarged for detailed re-examination. These were then karyo-
typed, using the classification of Hungerford and Nowell (1963).
At the conclusion of the experiment, all of the animals were sacrificed by
administering a sharp blow on the head. The internal organs and glands were
examined visually, with the aid of a dissecting microscope, for gross abnormalities.
TABLE 1










































The percent of cells with abnormal chromosomes and the changes in these
values during the course of the experiment are presented graphically in Figure 1.
All of the animals were generally healthy and in good condition at a start of the




FIGURE 1. Histogram of percentates of cells having abnormal chromosomes. On the abscissa
are the seven experimental weeks.
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treated rats appeared to be in poor condition, their eyes being pale and watery.
As the experiment progressed, these animals seemed to regain their health gradually,
and at the termination were in good condition. At the termination of this experi-
ment, none of the animals showed urinary bladder tumors or any other patho-
logical signs in other internal organs.
Although this study employed a small number of experimental animals, it was
believed that the difference in the CHA doses and the duration of the experiment
would produce discernible differences as far as abnormal chromosomes are con-
cerned. Observation of these data suggest that there were no discernible dif-
ferences. This is emphasized by the fact that the number of abnormal spreads
and percent of cells with abnormal chromosomes are nearly identical for both the
control and the experimental groups. Observation of these raw data (Table 2)
TABLE 2
Accumulative dose, number of chromosome spreads, abnormal observation, and percent of abnormal































































































































indicate that, from week to week, the percent of cells with abnormal chromosomes
was variable. However, in all experimental weeks, the values for the experi-
mental groups were similar to those of the control groups. This would suggest
that there were no differences between the experimental and control groups and
that the week-to-week differences that were observed were due to variations in
preparation techniques.
DISCUSSION AND CONCLUSIONS
A major difficulty of in vitro studies of chromosomes using micro-culture
techniques is the control and regulation of cellular growth. The factors which
are known to affect such growth are: temperature of incubation, incubation time
of the cells, non-sterile technique, and the number of viable leucocytes which are
present in the blood at the time when the blood sample was taken. We found
that 38°C, as compared to 37°C, gave better cellular growth. Incubation times of
90 to 94 hours also seemed to yield better cell growth then did the usually rec-
omended 72 hours. The number of viable leucocytes is almost impossible to
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regulate, as it depends on the physiological conditions of the individual animal.
During each week of the experiment, all of the samples were treated uniformly;
however some of the sample cells exhibited very good growth and others very
poor growth, which leads one to suspect that there may well be other unknown
factors which affect yield.
Another problem in the present study was the variation, from each experimental
animal, in the number of usable chromosome spreads. On occasion there were
yields of two to three chromsome spreads per field. In other instances, there were
either no usable spreads or only four or five on an entire slide.
The results of this study were compared with those of other available published
data. Legator, et at. (1969) first reported on in vivo studies and stated with
confidence that a dose of 10 rng/kg/day for five days IP injection in rats will in-
crease chromosome breaks in bone-marrow cells. Stoltz, et al. (1970) also re-
ported on in vitro studies of human leucocytes, where treatment with cyclamate,
CHA, and other related chemicals did induce chromosome breaks, breaks which
did not develop in untreated controls. At the present time, the above studies
have not yet been duplicated by other laboratory investigators.
There are no published reports available at the present time that indicate
negative effects of CHA on chromosome abnormalities. In an article appearing
in the New Scientist in 1968, and another which appeared in Family Health in
1969, experiments are described which were performed at the Institute of Experi-
mental Pathology and Toxicology, Albany Medical College, in New York. Studies
of chromosome breaks of 17 prisoners, who ingested from 3 to 16 grams of cycla-
mate and who excreted CHA in their urine, demonstrated no significant increases
in chromosome breaks. The detailed procedure of the above experiment was not
released by the original researchers, so no real comparison with this study can
be made. Also, in a letter to the editor of Science discussing the then recently
proposed FDA ban on the use of cyclamates, Inhorn and Meisner state (1970)
that: "Work in our laboratory and elsewhere has shown no mutagenic effect when
very high concentrations of cyclamate were put into cultures of normal human
cells." But again the detailed procedure used in this study is presently not avail-
able. Although we utilized only a limited number of animals, the results of this
study also suggest that there is no increase in numbers of chromosome breaks in
rats which were injected with 50 mg/Kg/day for periods of up to seven weeks.
The fact that we found no urinary bladder tumors agrees with the two-year
study of Price (1970), in which fifty rats were fed CHA and only one animal
developed a bladder tumor. It also agrees with Shabad's (1963) work, in which
CHA was administered both orally and subcutaneously without producing any
bladder tumors. We, in fact, were unable to find tumors of any kind associated
with body organs on our animals.
It is recognized that this combination in vivo and in vitro study has limitations.
It is possible that gross damage occurred in vivo study because damaged cell lines
could not have repoduced and would not be present for in vitro analysis. It did
not appear that fewer usable spreads were obtained from the experimental animals
than were available from the control animals. However, this is an observation not
supported by any other reported data.
In conclusion, our data support the premise that CHA has little if any effect
on the chromosomes of rats; however, for the above results, it would appear that
a more extensive study using larger numbers of animals, longer treatment, and
expanded in vitro techniques would be desirable.
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